<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00780559</url>
  </required_header>
  <id_info>
    <org_study_id>B6017-R</org_study_id>
    <secondary_id>INMED 42940</secondary_id>
    <nct_id>NCT00780559</nct_id>
  </id_info>
  <brief_title>Improving Neuropathy and Mobility in People With Early Diabetes</brief_title>
  <acronym>INMED</acronym>
  <official_title>Improving Neuropathy and Mobility in Subjects With Early Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Maryland, College Park</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if an individually tailored diet and physical
      enhancement program can improve mobility, physical activity, and neuropathy in people with
      early diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuropathy is the most common complication of diabetes mellitus. Impaired glucose regulation
      (IGR) is associated with development of peripheral neuropathy coupled with gait and mobility
      impairment that may be disabling for the patient. Recent novel data from the investigators'
      group indicates that improved diet and exercise can significantly improve and even reverse
      neuropathy associated with IGR, however this has not been tested as a specific intervention
      in a controlled diabetes complications trial. IGR includes patients with early type 2
      diabetes mellitus (T2DM), impaired glucose tolerance (IGT), and impaired fasting glucose
      (IFG) based on standardized criteria for the diagnosis of T2DM. The investigators hypothesize
      that, compared to IGR participants advised to follow the current standard care
      recommendations on diet and exercise (Standard Care or &quot;SC&quot;), IGR participants undergoing a
      Tailored Diet and Physical Activity (TDPA) enhancement program will show greater improvement
      in the 6 minute walk test (6MW) and will show a greater reduction in markers of neuropathy
      progression e.g. intraepidermal nerve fiber density (IEFND). Furthermore, the investigators
      will test the hypothesis that improvement in measures of neuropathy, mobility function and
      physical activity (PA) will correlate strongly with each other and with improvement in
      specific measures of metabolic function, and weight loss. This proposal will permit us to
      determine if TDPA can improve mobility and induce nerve regeneration in subjects with early
      diabetes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2009</start_date>
  <completion_date type="Actual">February 8, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Six Minute Walk (6MW) Test</measure>
    <time_frame>Six Months</time_frame>
    <description>Measures distance covered by participant when walking at a brisk pace without running for six minutes in feet.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in 6-Minute-Walk Test Measured in Feet Between Baseline and 12 Months</measure>
    <time_frame>Baseline and 12 Months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraepidermal Nerve Fiber Density (Distal Leg)</measure>
    <time_frame>12 Months</time_frame>
    <description>Measure of the number of skin fibers/mm in the lower extremity (distal leg) at 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraepidermal Nerve Fiber Density (IENFD) at the Proximal Thigh</measure>
    <time_frame>12 Months</time_frame>
    <description>Measure of the number of skin fibers/mm in the lower extremity (proximal thigh) at 12 months</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Physical Activity (PA) at 12 Months as Measured by the CHAMPS (Community Health Activities Model Program for Seniors) Activity Scale</measure>
    <time_frame>Baseline and 12 Months</time_frame>
    <description>Physical Activity measured by CHAMPS provides an estimated caloric expenditure of subject based on weight and weekly physical activity, as assessed by the questionnaire. Change in physical activity is determined by the difference in daily caloric expenditure at baseline and 12 months.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Diabetes</condition>
  <condition>Physical Activity</condition>
  <arm_group>
    <arm_group_label>Tailored Diet and Physical Activity</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will receive an individually tailored diet and physical activity enhancement program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tailored Diet and Physical Activity</intervention_name>
    <description>Subjects will receive an individually tailored diet and physical activity enhancement program</description>
    <arm_group_label>Tailored Diet and Physical Activity</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard of Care</intervention_name>
    <description>Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IGR at the time of screening or within three months of screening. This definition
             includes patients with impaired fasting glucose (IFG), impaired glucose tolerance
             (IGT), and early diabetes. Patients can be included if they have an increased risk for
             diabetes with a HBA1C &gt; or = 5.7% (using a method certified by the National
             Glycohemoglobin Standardization Program), or they have diabetes with a HBA1C &gt; or
             equal to 6.5%, or an abnormal fasting venous glucose, or abnormal venous glucose
             values following a 75 gram oral load. Glucose values are as defined (mg/dl): IFG
             fasting greater than 100 mg/dl, IGT- fasting less than 126, 2 h 140-199, or diabetes -
             fasting glucose &gt; 126, 2 h &gt; 200 based on the Standards for Medical Care in Diabetes
             2010 by the American Diabetes Association.

          -  The HbA1c may be normal, but must be &lt;8%.

          -  If diabetic subjects are on medication, they should be stable on medication for at
             least 3 months prior to entering the study. Addition or change in antidiabetic
             medications after enrollment does not affect participation or group assignment.

          -  No risk factors for other causes for neuropathy (determined by a medical history,
             family history, history of medications, occupational history, history of exposure to
             toxins, physical and neurological examinations, and laboratory studies).

          -  Clinical signs or symptoms of neuropathy as determined by the treating neurologists
             history and physical exam, plus an abnormality of one of the following: nerve
             conduction studies (NCS), Quantitative Sudomotor Autonomic Reflex Testing (QSART),
             Quantitative Sensory Testing (QST), or IENFD.

          -  Age range from 30 to 80 years inclusive at the time of screening

          -  Medically stable at the time of enrollment.

          -  Able to participate in a standing exercise program without constant standby
             monitoring.

          -  Women of childbearing potential must be using an acceptable method of contraception to
             prevent pregnancy when they are enrolled in the study and must agree to continue to
             practice an acceptable method of contraception for the duration of their participation
             in the study.

          -  Patient must agree to taking an alternative medication to coumadin when undergoing a
             skin biopsy

          -  Willing to complete weekly self-report questionnaires.

          -  Willing to accept assignment to either training group.

          -  Willing and able to increase activity level and exercise independently at home.

        Exclusion Criteria:

          -  Pregnant women, prisoners, institutionalized subjects and other at risk subjects will
             not be included in this study.

          -  Taking insulin.

          -  Etiology of sensorimotor neuropathy other than IGR based on careful clinical and
             laboratory evaluation.

          -  Current severe medical conditions that are active on the day of enrollment and would
             affect a patient's ability to complete study. This may include active advanced current
             ischemic heart disease (e.g., angina or congestive heart failure), permanent residual
             lower extremity weakness or loss of balance resulting from a stroke, active severe
             obstructive or restrictive pulmonary disease, ongoing cancer treatment, renal failure
             currently requiring dialysis, or severe ongoing peripheral vascular disease.

          -  An inability to understand or cooperate with the procedures of the trial or refusal to
             sign the informed consent.

          -  Patients who are unable to answer questions correctly on the Evaluation to Sign
             Consent (ESC) tool.

          -  Significant other neurologic, rheumatological, neuromuscular, or other extremity
             conditions that limit safe exercise or weight bearing.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James W Russell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>20742</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Ann Arbor Healthcare System, Ann Arbor, MI</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Zilliox L, Peltier AC, Wren PA, Anderson A, Smith AG, Singleton JR, Feldman EL, Alexander NB, Russell JW. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology. 2011 Mar 22;76(12):1099-105. doi: 10.1212/WNL.0b013e3182120147.</citation>
    <PMID>21422460</PMID>
  </results_reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>October 24, 2008</study_first_submitted>
  <study_first_submitted_qc>October 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2008</study_first_posted>
  <results_first_submitted>May 9, 2019</results_first_submitted>
  <results_first_submitted_qc>September 6, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">September 9, 2019</results_first_posted>
  <last_update_submitted>September 6, 2019</last_update_submitted>
  <last_update_submitted_qc>September 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuropathy</keyword>
  <keyword>diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 9, 2010</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT00780559/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Participants were excluded from the study prior to assignment for groups (n=12) due to failure of screening (e.g. not meeting inclusion/exclusion criteria, n=10) or declined to participate (n=2.)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Tailored Diet and Physical Activity</title>
          <description>Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program</description>
        </group>
        <group group_id="P2">
          <title>Standard of Care</title>
          <description>Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Participants were IGR patients with neuropathy, including early type 2 diabetes mellitus (T2DM - within 2 years of diagnosis), impaired glucose tolerance (IGT), and impaired fasting glucose (IFG) patients.</population>
      <group_list>
        <group group_id="B1">
          <title>Tailored Diet and Physical Activity</title>
          <description>Subjects will receive an individually tailored diet and physical activity enhancement program</description>
        </group>
        <group group_id="B2">
          <title>Standard of Care</title>
          <description>Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.81" spread="8.25"/>
                    <measurement group_id="B2" value="61.03" spread="7.83"/>
                    <measurement group_id="B3" value="61.38" spread="7.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (Body Mass Index), Categorical</title>
          <description>Body Mass Index defined as kg/m^2 at the time of screening/baseline visit.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>BMI &lt; 30 kg/m^2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>BMI 30 - 40 kg/m^2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>BMI &gt; 40 kg/m^2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (Body Mass Index), Continuous</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.21" spread="7.65"/>
                    <measurement group_id="B2" value="30.83" spread="7.06"/>
                    <measurement group_id="B3" value="31.89" spread="7.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Six Minute Walk (6MW) Test</title>
        <description>Measures distance covered by participant when walking at a brisk pace without running for six minutes in feet.</description>
        <time_frame>Six Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tailored Diet and Physical Activity</title>
            <description>Subjects will receive an individually tailored diet and physical activity enhancement program</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
          </group>
        </group_list>
        <measure>
          <title>Six Minute Walk (6MW) Test</title>
          <description>Measures distance covered by participant when walking at a brisk pace without running for six minutes in feet.</description>
          <units>feet</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156.644156" spread="35.364227"/>
                    <measurement group_id="O2" value="61.257846" spread="35.840649"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in 6-Minute-Walk Test Measured in Feet Between Baseline and 12 Months</title>
        <time_frame>Baseline and 12 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tailored Diet and Physical Activity</title>
            <description>Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 6-Minute-Walk Test Measured in Feet Between Baseline and 12 Months</title>
          <units>feet</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="188.415845" spread="34.346235"/>
                    <measurement group_id="O2" value="100.559319" spread="36.399507"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraepidermal Nerve Fiber Density (Distal Leg)</title>
        <description>Measure of the number of skin fibers/mm in the lower extremity (distal leg) at 12 months</description>
        <time_frame>12 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tailored Diet and Physical Activity</title>
            <description>Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
          </group>
        </group_list>
        <measure>
          <title>Intraepidermal Nerve Fiber Density (Distal Leg)</title>
          <description>Measure of the number of skin fibers/mm in the lower extremity (distal leg) at 12 months</description>
          <units>fibers/mm</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28627099" spread="0.81830712"/>
                    <measurement group_id="O2" value="-0.38943425" spread="0.84781677"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intraepidermal Nerve Fiber Density (IENFD) at the Proximal Thigh</title>
        <description>Measure of the number of skin fibers/mm in the lower extremity (proximal thigh) at 12 months</description>
        <time_frame>12 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tailored Diet and Physical Activity</title>
            <description>Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
          </group>
        </group_list>
        <measure>
          <title>Intraepidermal Nerve Fiber Density (IENFD) at the Proximal Thigh</title>
          <description>Measure of the number of skin fibers/mm in the lower extremity (proximal thigh) at 12 months</description>
          <units>fibers/mm</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.53825016" spread="0.83395303"/>
                    <measurement group_id="O2" value="-0.54419990" spread="0.87926529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Physical Activity (PA) at 12 Months as Measured by the CHAMPS (Community Health Activities Model Program for Seniors) Activity Scale</title>
        <description>Physical Activity measured by CHAMPS provides an estimated caloric expenditure of subject based on weight and weekly physical activity, as assessed by the questionnaire. Change in physical activity is determined by the difference in daily caloric expenditure at baseline and 12 months.</description>
        <time_frame>Baseline and 12 Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Tailored Diet and Physical Activity</title>
            <description>Tailored Diet and Physical Activity: Subjects will receive an individually tailored diet and physical activity enhancement program</description>
          </group>
          <group group_id="O2">
            <title>Standard of Care</title>
            <description>Standard of Care: Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Physical Activity (PA) at 12 Months as Measured by the CHAMPS (Community Health Activities Model Program for Seniors) Activity Scale</title>
          <description>Physical Activity measured by CHAMPS provides an estimated caloric expenditure of subject based on weight and weekly physical activity, as assessed by the questionnaire. Change in physical activity is determined by the difference in daily caloric expenditure at baseline and 12 months.</description>
          <units>kcal/day</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-735.249060" spread="886.986000"/>
                    <measurement group_id="O2" value="296.998122" spread="937.935990"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data for each participant was collected over one year per study patient, or the duration of the study for each participant.</time_frame>
      <desc>The definition of adverse events and/or serious adverse events does not differ from that which is listed here on clinicaltrials.gov. Adverse Events were collected from patient reports and phone call follow-ups.</desc>
      <group_list>
        <group group_id="E1">
          <title>Tailored Diet and Physical Activity</title>
          <description>Subjects will receive an individually tailored diet and physical activity enhancement program</description>
        </group>
        <group group_id="E2">
          <title>Standard of Care</title>
          <description>Subjects will be told to reduce their baseline weight by 7% and exercise for 150 minutes/week. There is no tailored, directed program.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Skin Irritation</sub_title>
                <description>Participant complained of skin rash at biopsy wound site. This is not outside of risks, and participant was irritated by the bandage.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="40"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Coordinator</name_or_title>
      <organization>University of Maryland School of Medicine</organization>
      <phone>(410) 328-6583</phone>
      <email>inmed@som.umaryland.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

